Mylan Receives DOJ Subpoena About Generic Pricing

Mylan said it has received a subpoena from the U.S. Justice Department’s antitrust division related to the marketing and pricing of its generic antibiotic Doxycycline.

from WSJ.com: US Business http://ift.tt/1Q51jcK
via IFTTT